An in vitro and in vivo evaluation of the efficacy of recombinant human liver prolidase as a catalytic bioscavenger of chemical warfare nerve agents

References

• Aleti V, Reddy GB, Parikh K, et al. (2013). Persistent and high-level expression of human liver prolidase in vivo in mice using adenovirus. Chem Biol Interact 203:191–195
   PubMed Web of Science ®Google Scholar
• Benschop HP, Konings CA, van Genderen J, de Jong LP. (1984). Isolation, in vitro activity, and acute toxicity in mice of the four stereoisomers of soman. Fundam Appl Toxicol 4:S84–S95
   PubMedGoogle Scholar
• Billecke SS, Primo-Parmo SL, Dunlop CS, et al. (1999). Characterization of a soluble mouse liver enzyme capable of hydrolyzing diisopropyl phosphorofluoridate. Chem Biol Interact 119–120:251–256
   PubMed Web of Science ®Google Scholar
• Brimblecombe RW. (1977). Drugs acting on central cholinergic mechanisms and affecting respiration. Pharmacol Ther B 3:65–74
   PubMedGoogle Scholar
• Broomfield CA, Maxwell DM, Solana RP, et al. (1991). Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 259:633–638
   PubMed Web of Science ®Google Scholar
• Costante M, Biggemann L, Alamneh Y, et al. (2012). Hydrolysis potential of recombinant human skin and kidney prolidase against diisopropylfluorophosphate and sarin by in vitro analysis. Toxicol In Vitro 26:182–188
   PubMed Web of Science ®Google Scholar
• De Candole CA, Douglas WW, Evans CL, et al. (1953). The failure of respiration in death by anticholinesterase poisoning. Br J Pharmacol Chemother 8:466–475
   PubMed Web of Science ®Google Scholar
• Dickson EW, Bird SB, Gaspari RJ, et al. (2003). Diazepam inhibits organophosphate-induced central respiratory depression. Acad Emerg Med 10:1303–1306
   PubMed Web of Science ®Google Scholar
• Dirnhuber P, French MC, Green DM, et al. (1979). The protection of primates against soman poisoning by pretreatment with pyridostigmine. J Pharm Pharmacol 31:295–299
   PubMed Web of Science ®Google Scholar
• diTargiani RC, Chandrasekaran L, Belinskaya T, Saxena A. (2010). In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity. Chem Biol Interact 187:349–354
   PubMed Web of Science ®Google Scholar
• Duysen EG, Parikh K, Aleti V, et al. (2011). Adenovirus-mediated human paraoxonase1 gene transfer to provide protection against the toxicity of the organophosphorus pesticide toxicant diazoxon. Gene Ther 18:250–257
   PubMed Web of Science ®Google Scholar
• Endo F, Matsuda I, Ogata A, Tanaka S. (1982). Human erythrocyte prolidase and prolidase deficiency. Pediatr Res 16:227–231
   PubMed Web of Science ®Google Scholar
• Gray AP. (1984). Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents. Drug Metab Rev 15:557–589
   PubMed Web of Science ®Google Scholar
• Gupta RD, Goldsmith M, Ashani Y, et al. (2011). Directed evolution of hydrolases for prevention of G-type nerve agent intoxication. Nat Chem Biol 7:120–125
   PubMed Web of Science ®Google Scholar
• Haigh JR, Johnston SR, Peters BM, et al. (2005). Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicity. Chem Biol Interact 157–158:381–382
   PubMed Web of Science ®Google Scholar
• Hill CM, Li WS, Cheng TC, et al. (2001). Stereochemical specificity of organophosphorus acid anhydrolase toward p-nitrophenyl analogs of soman and sarin. Bioorg Chem 29:27–35
   PubMed Web of Science ®Google Scholar
• Huang YJ, Huang Y, Baldassarre H, et al. (2007). Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning. Proc Natl Acad Sci USA 104:13603–13608
   PubMed Web of Science ®Google Scholar
• Kokturk A, Kaya TI, Ikizoglu G, Koca A. (2002). Prolidase deficiency. Int J Dermatol 41:45–48
   PubMedGoogle Scholar
• Koplovitz I, Stewart JR. (1994). A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit. Toxicol Lett 70:269–279
   PubMed Web of Science ®Google Scholar
• Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
   PubMed Web of Science ®Google Scholar
• Lenz DE, Maxwell DM, Koplovitz I, et al. (2005). Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. Chem Biol Interact 157–158:205–210
   PubMed Web of Science ®Google Scholar
• Lenz DE, Yeung D, Smith JR, et al. (2007). Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 233:31–39
   PubMed Web of Science ®Google Scholar
• Letant SE, Kane SR, Hart BR, et al. (2005). Hydrolysis of acetylcholinesterase inhibitors–organophosphorus acid anhydrolase enzyme immobilization on photoluminescent porous silicon platforms. Chem Commun (Camb) 7:851–853
   PubMed Web of Science ®Google Scholar
• Marti J, Reverte C, Roig M, et al. (1985). Use of diazepam in organophosphate insecticide poisoning. An Esp Pediatr 23:299–301
   PubMedGoogle Scholar
• Masson P. (2011). Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol Lett 206:5–13
   PubMed Web of Science ®Google Scholar
• Myara I, Charpentier C, Lemonnier A. (1982). Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta 125:193–205
   PubMed Web of Science ®Google Scholar
• Myara I, Cosson C, Moatti N, Lemonnier A. (1994). Human kidney prolidase–purification, preincubation properties and immunological reactivity. Int J Biochem 26:207–214
   PubMedGoogle Scholar
• Otto TC, Harsch CK, Yeung DT, et al. (2009). Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes. Biochemistry 48:10416–10422
   PubMed Web of Science ®Google Scholar
• Otto TC, Kasten SA, Kovaleva E, et al. (2010). Purification and characterization of functional human paraoxonase-1 expressed in Trichoplusia ni larvae. Chem Biol Interact 187:388–392
   PubMed Web of Science ®Google Scholar
• Palka JA. (1996). The role of prolidase as an enzyme participating in the metabolism of collagen. Rocz Akad Med Bialymst 41:149–160
   PubMedGoogle Scholar
• Palka JA, Miltyk W, Karna E, Wolczynski S. (1996). Modulation of prolidase activity during in vitro aging of human skin fibroblasts the role of extracellular matrix collagen. Tokai J Exp Clin Med 21:207–213
   PubMedGoogle Scholar
• Parikh K, Duysen EG, Snow B, et al. (2011). Gene-delivered butyrylcholinesterase is prophylactic against the toxicity of chemical warfare nerve agents and organophosphorus compounds. J Pharmacol Exp Ther 337:92–101
   PubMed Web of Science ®Google Scholar
• Shih TM, McDonough JH. Jr (1999). Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol Biochem Behav 64:147–153
   PubMed Web of Science ®Google Scholar
• Shih TM, Rowland TC, McDonough JH. (2007). Anticonvulsants for nerve agent-induced seizures: the influence of the therapeutic dose of atropine. J Pharmacol Exp Ther 320:154–161
   PubMed Web of Science ®Google Scholar
• Sjostrom H, Noren O, Josefsson L. (1973). Purification and specificity of pig intestinal prolidase. Biochim Biophys Acta 327:457–470
   PubMed Web of Science ®Google Scholar
• Wang SH, Zhi QW, Sun MJ. (2005). Purification and characterization of recombinant human liver prolidase expressed in Saccharomyces cerevisiae. Arch Toxicol 79:253–259
   PubMed Web of Science ®Google Scholar
• Wang SH, Zhi QW, Sun MJ. (2006). Dual activities of human prolidase. Toxicol In Vitro 20:71–77
   PubMed Web of Science ®Google Scholar
• Wolfe AD, Blick DW, Murphy MR, et al. (1992). Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol Appl Pharmacol 117:189–193
   PubMed Web of Science ®Google Scholar
• Yokoyama K, Araki S, Murata K, et al. (1998). Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning. J Physiol Paris 92:317–323
   PubMed Web of Science ®Google Scholar